{"name":"Oriel Therapeutics","slug":"oriel-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE5ueGZFZ3Y4Zno2UV9oUW9ENHBPeG9fNW9Tb0phN2RFNU5zT0tBbFo5czJoX1NjaUd3alIzMGpxTkNHMDBtclhpaWdqRnNwMEsxSV81YzA3Q1BHS0hlbC1DaHJ2WW9ETENVR3RZUw?oc=5","date":"2022-01-06","type":"pipeline","source":"Pharma Voice","summary":"Talent Pool - Pharma Voice","headline":"Talent Pool","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxOWkJ4ZUFzLUNjYUZSWVpwRHlLVHNoZmF3TXZaNFpZX29fR2xnaTcxYVRTSmpxNU9kUFNvRE5nVklfOHE4MXFfdjdRNkZURDIxWnRiOVpBNDV2ZHhJbGpaUEprVnJ1eFVSSWN2WVZJd3A4aVM0dHM3eGJGX3NhUWRjbjg3a2RLMjFsS0lJLXMtNy1qR3BXS1AxMzNnVlEyUQ?oc=5","date":"2020-08-04","type":"pipeline","source":"PharmTech.com","summary":"Dry powder inhalers: challenges and goals for next generation therapies - PharmTech.com","headline":"Dry powder inhalers: challenges and goals for next generation therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxQSGVpbHdwMzRQRWRqanRzNzg4OVRycXBfcWg3RnJfbll5dUk1U0xvZTgxYlJQMzU3NFViVDRsLUp0X0wzN3FWdzBEdFhiWDF5anItZ3daYjZNdnFFVmV5N2dmWHlXS1Fvc1lRU2EtbkdBV2g2YkNtNFZwaVZzS3dkcTZUOUtTUkd1T1dyakF6bzNsbGlWSkk2aUZfV1dJeHdaTnoyY1R5Q3hiUWhhTmlBUEFCcnU4Zw?oc=5","date":"2019-07-08","type":"regulatory","source":"Novartis","summary":"FDA accepts Sandoz regulatory submission for a generic version of Advair Diskus® - Novartis","headline":"FDA accepts Sandoz regulatory submission for a generic version of Advair Diskus®","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}